Radioimmunodetection and Radioimmunotherapy of Malignant Melanoma: A Review
Authors:
- 1 January 1993
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 32 (7-8) , 717-721
Abstract
Radioimmunodetection utilizing monoclonal antibodies to various melanoma-associated surface antigens has been studied by several investigators during the past ten years. In the early trials, antibodies were labeled with 131I or 111In, but now 99mTc is almost exclusively used because of its more favorable energy for gamma camera imaging. Excellent specificity has been achieved in most studies, whereas sensitivity has been less good. In a recent European multicenter study on 493 patients sensitivity was 79% and specificity 96%. In this largest study on melanoma so far performed many previously unknown metastatic deposits were identified indicating that radioimmunodetection has a role in the management of metastatic disease. The clinical utility of immunoscintigraphy in localization of regional lymph node metastases has been documented in several investigations in recent years, indicating that this method can be used in the preoperative evaluation of patients. Radioimmunodetection has also been successfully used in the differential diagnosis of ocular lesions. However, conclusive evidence of improved patient outcome resulting from the earlier detection of melanoma lesions by immunoscintigraphy is still lacking. Anti-melanoma antibodies labeled with alpha- and beta-emitting isotopes are potential therapeutic agents, but so far there is little clinical experience with radio-immunotherapy of metastatic melanoma.Keywords
This publication has 16 references indexed in Scilit:
- Immunoscintigraphy in malignant melanomaNuclear Medicine Communications, 1993
- Anti-melanoma antibodies bind preferentially to diploid metastases in immunoscintigraphyNuclear Medicine Communications, 1990
- European multicentre study on melanoma immunoscintigraphy by means of99mTc-labelled monoclonal antibody fragmentsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- 131I-Metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection?European Journal of Nuclear Medicine and Molecular Imaging, 1989
- Immunoscintigraphy with 99mTc labelled F(ab?)2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1987
- Monoclonal Antibody Imaging of Human MelanomaAnnals of Surgery, 1986
- Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms.Proceedings of the National Academy of Sciences, 1980
- Supraceliac Pseudoaneurysm of Abdominal AortaArchives of Surgery, 1975
- Gallium-67 scintigraphy in malignant melanomaCancer, 1973
- Visualizing Human Malignant Melanoma and Metastases1968